Janus Henderson Investors

Janus Henderson Investors

Janus Henderson Investors

Xconomy

Kymera Therapeutics Unveils IPO Pitch for Protein Degradation

$257,000,000 Venture capital (Series B)
FinSMEs

Thrive Earlier Detection Raises $257M in Series B Financing

$54,000,000 Venture capital (Series B)
Pulse 2.0

Olema Oncology Secures $54 Million To Advance Lead Program In Breast Cancer

$72,500,000 Venture capital (Series D)
FinSMEs

BioAtla Raises $72.5M In Series D Financing

$150,000,000 Venture capital (Series B)
FinSMEs , Pulse 2.0

C4 Therapeutics Raises $170M in Funding

$310,000,000 Venture capital (Series C)
ChinaMoneyNetwork

CBC Group-incubated Everest Medicines Completes $310M Series C Round – China Money Network

$110,000,000 Venture capital (Series D)
FinSMEs

SutroVax Raises $110M in Series D Financing

$102,000,000 Venture capital (Series C)
FinSMEs

Kymera Therapeutics Raises $102M in Series C Financing

$100,000,000 Venture capital (Series D)
FinSMEs

Forma Therapeutics Closes $100M Series D Financing

$181,700,000 IPO
PE HUB

Phathom Pharmaceuticals goes public

FinSMEs

Sojournix Completes $44M Series C Financing

$70,000,000 Venture capital (Series B)
PE HUB , FinSMEs

Akero Therapeutics locks in $70 mln Series B

$65,000,000 Venture capital (Series B)
PE HUB

Kymera Therapeutics attracts $65 mln Series B

$65,000,000 Venture capital (Series A)
FinSMEs

Akero Therapeutics Closes $65M Series A Financing

Funding Health Science
$85,000,000 Venture capital (Series C)
PE HUB , FinSMEs

SutroVax reels in $85 mln Series C

Messaging
$270,000,000 Venture capital (Series A)
PE HUB

| Europe’s biggest private biotech company raises $270 million: Reuters

Health Funding
Xconomy

SutroVax Lands $64M From Roche, Others to Back Vaccine Studies

Health Funding
$73,000,000 Venture capital (Series A)
FinSMEs

C4 Therapeutics Closes $73M Series A Financing

Science Health Funding
$22,000,000 Venture capital (Series A)
Xconomy

With $22M Shot of Venture, Sutro Spinout Aims For Better Vaccines

Health